Windrose Health Investors LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Windrose Health Investors LLC
CRD #160311
SEC #801-73671
CIK #
AUM 7,013.5 M (2026-05-05)
Employees 22 (77% Investors, 0% Brokers)
Fees
Minimum
Phone212-887-2105
Address375 Park Ave
New York, NY 10152
Source [IAPD] [Website] [LinkedIn]
Total AUM ($B)
7.56.04.53.01.50.02010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5 - FEES AND COMPENSATION

Fee Schedules

The Adviser receives an annual management fee from each Fund. During the investment period, the
annual management fee is equal to 2% of the capital commitments. Thereafter, the annual management
fee ranges from 1.5% to 2% (depending on the Fund and the length of time expired since the end of the
investment period) and is calculated based on invested capital (including, where applicable, a Fund
borrowing component (including interest expenses) and the amount of any capitalized transaction fees or
expenses), less capital returned to investors and as adjusted for any permanent write downs in the value
of investments. In addition, the Adviser (or its affiliate) receives a carried interest from certain Funds equal
to 20% of the profits of the Fund if the investors achieve at least an annual 8% return. Management fees
and carried interests are not negotiable by investors in the Funds. However, certain employees and affiliates
of WindRose do not pay the aforementioned fees. Specific information about the management fees, carried
interests, and expense arrangements for each Fund is provided in each Fund’s organizational documents
and/or offering materials.

Calculation and Deduction of Advisory Fees

The management fee is payable quarterly in advance by each Fund. While the management fee is
generally paid by calling unfunded capital commitments, the Adviser may pay the fee out of current income
and disposition proceeds of each Fund. Management fees generally will not be reimbursed or refunded
under a Fund’s organizational documents in the event of realizations, dispositions or partial write-downs or
write-offs that occur partway through the relevant calculation period. The carried interest is allocated to the
capital account of the Adviser (or its affiliate) and is generally distributed by each Fund either (1) after
investors have received 100% of their capital contributions and an annual 8% compounded return or (2)
after investors have received 100% of their capital contributions (including allocated expense contributions)
and an annual 8% compounded return related to all realized investments.

Other Fees and Expenses

The Adviser pays all of its ordinary administrative and overhead expenses incurred in connection with
managing, originating and monitoring investments, including its employees’ salaries, rent and utilities. Each
Fund pays all other costs and expenses of the Fund that are not reimbursed by portfolio companies,
including legal, auditing, consulting, financing, accounting, custodial and other professional fees and
expenses; expenses associated with the Fund’s financial statements, tax returns and Schedule K-1s; out-
of-pocket expenses incurred in connection with transactions not consummated; expenses of the Fund’s
advisory committee and annual meetings of the investors; insurance (including directors and officers
insurance); other expenses associated with the acquisition, holding and disposition of its investments,
including extraordinary expenses (such as litigation, if any); and any taxes, fees or other governmental
charges levied against the Fund.

The Adviser and its affiliates may from time to time receive fees from portfolio companies, such as directors’
fees, financial consulting fees and monitoring fees relating to the Funds’ investments. A percentage of
those fees (ranging from 50% to 100% depending on the Fund) is reimbursed to the investors through a
management fee offset mechanism.

Prepaid Fees

The management fee is payable quarterly in advance. Installments of the management fee payable for any
period other than a full three-month period are adjusted on a pro rata basis according to the actual number
of days in such period.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7 - TYPES OF CLIENTS

The Adviser provides investment advisory services to the Funds and associated co-investment vehicles.
The minimum amount investors invest for participation in a Fund is set forth in the Fund’s offering materials
and varies from Fund to Fund, subject to waiver by the Adviser. Fund investors generally must meet
minimum net worth and other criteria as required by applicable federal securities laws and regulations,
including meeting the requirements to be deemed “accredited investors” (as defined in Regulation D under
the Securities Act) and/or “qualified purchasers” (as defined in Section 2(a)(51) of the Investment Company
Act) as required by the governing Fund documents.
Type Form D Funds Date Sold AUM
PE Windrose Health Investors VII-G LP [2026-03-31] 45.0 M
Filed 2025-12-08 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE WR Riviera Co-Invest LP [2026-03-31] 294.6 M
Filed 2025-01-16 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE Windrose Health Investors VII-A LP 2025-09-19 1,503.1 M
PE Windrose Health Investors VII LP 2025-09-19 1,312.4 M
PE Maroon Investors LP 2024-03-29 362.3 M
PE Windrose Health Investors VI-A LP 2022-03-30 883.6 M
PE Windrose Health Investors VI LP [2022-03-30] 1,224.0 M 1,145.1 M
Filed 2022-09-20 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE Windrose Health Investors V-A LP 2018-11-16 319.7 M
PE Windrose Health Investors V LP [2018-11-16] 705.1 M 842.0 M
Offered $705,075,000 · Filed 2019-01-08 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration More than one year · Net Assets Decline to Disclose
PE Windrose Health Investors Executive IV LP 2017-03-29 2.2 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 12 7.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 12 7.0
By Discretionary
Discretionary 12 7.0
Non-Discretionary 0 0.0
Total 12 7.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 7.0
Total 12 7.0
Form D Directors Role # Filings # Firms 2011 - 2026
Curtis Lane Executive Officer 8 3
Oliver Moses Executive Officer 16 2
Alexander Buzik Executive Officer 7 2
Christopher Burnes Executive Officer 4 2
Firm Profile (Form ADV)
Discretionary AUM$0.3B
ServesInstitutional
Fund TypesPrivate Equity
Comparable Firms State AUM
Butterfly Equity LP
CA 7,084.6 M
Crestview Advisors LLC
NY 7,082.4 M
Argo Infrastructure Partners LP
NY 7,065.0 M
Five Point Infrastructure LLC
TX 7,053.2 M
US Innovative Technology Capital Management LLC
PA 7,033.5 M
One Madison Group LLC
NY 7,024.0 M
Medley Partners Management LLC
CA 6,963.4 M
Oceansound Partners LP
NY 6,948.1 M
Mesirow Financial Private Equity Advisors Inc
IL 6,944.4 M
Stellex Capital Management LLC
NY 6,914.3 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com